Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://mayasyqm889967.thechapblog.com/37905752/semaglutide-a-potential-solution-for-metabolic-disorders